Food and Drug Administration
Food and Drug Administration Newswire

Food and Drug Administration Newswire

Comprehensive Real-Time News Feed for Food and Drug Administration.

Results 1 - 20 of 19,308 in Food and Drug Administration

  1. Biofrontera delivers excellent business development in Q1Read the original story

    1 hr ago | PR-inside.com

    Biofrontera AG / Biofrontera delivers excellent business development in Q1 . Processed and transmitted by NASDAQ OMX Corporate Solutions.

    Comment?

  2. Swiss stocks - Factors to watch on May 29Read the original story

    16 min ago | Reuters

    Societe Generale Private Banking , MediBank AG, LBBW AG, and Scobag Privatbank AG cut deals with the U.S. Department of Justice to avoid prosecution for helping Americans evade taxes, the DOJ said on Thursday. The U.S. Food and Drug Administration has asked manufacturers of dermal fillers, which includes Galderma, unit of Nestle SA, to update their labeling to reflect the possible risk of serious injuries caused by unintentional injection of the fillers into the blood vessels in the face.

    Comment?

  3. DaVita expands renal, diabetes clinical trial services in EURead the original story w/Photo

    1 hr ago | Drug Researcher

    Thanks to the expansion, which will include the addition of 10 physician leaders across the three countries, DaVita will be able to conduct late phase clinical trials outside of the US for the first time. Amy Young, VP and general manager of DaVita Clinical Research, told Outsourcing-Pharma.com that the expansion in Europe will include renal and diabetes clinical trials.

    Comment?

  4. Analysis reveals more than one-quarter of all supermarket food contains toxic trans fatsRead the original story w/Photo

    1 hr ago | NewsTarget.com

    ... issue of trans fats, which aren't always identifiable on food labels. This is because the U.S. Food and Drug Administration (FDA) allows processed food manufacturers to label their products as containing "no trans fats " when they contain half a ...

    Comment?

  5. FDAnews Announces a " Medical Device Cybersecurity Quality Assurance:...Read the original story w/Photo

    1 hr ago | Insurance News Net

    Network connectivity opens up a wealth of possibilities for medical devices, but it also exposes a minefield of potential liabilities. Devices transmit data on the user's condition to healthcare professionals, but can manufacturers be sure the information doesn't fall into unauthorized hands? Even more vitally, if a device can send data out, malware or hackers could possibly get in.

    Comment?

  6. China Probes Official Who Supervised Medical Device SectorRead the original story

    2 hrs ago | The Washington Post

    Tong Min, the director of the China Food and Drug Administration's department of medical device supervision has been probed over "serious discipline violations," the Communist Party's Central Commission for Discipline Inspection said on its website Friday. The health industry has drawn greater scrutiny from the Chinese government in recent years.

    Comment?

  7. Feds' focus on genetic treatments a boon to biotechRead the original story

    2 hrs ago | Boston Herald

    ... er Institute $130 million in funds to study the genetic differences that cause cancer. The U.S. Food and Drug Administration would receive $70 million to evaluate next-generation genetic tests.

    Comment?

  8. FDAnews Announces - Medical Device Cybersecurity Quality Assurance:...Read the original story w/Photo

    2 hrs ago | PRWeb

    Sign up to attend the FDAnews webinar Medical Device Cybersecurity Quality Assurance on Tuesday, June 23, 2015 and learn what medical device manufacturers should be doing with their quality assurance strategies to protect their devices. Plus, learn how other industries are dealing with this issue through responsible disclosure policies and what these policies mean to the relationship with regulators.

    Comment?

  9. Lung cancer treatment hope raisedRead the original story w/Photo

    2 hrs ago | Andover Advertiser

    ... known as MPDL3280A. The drug, which had been awarded breakthrough therapy designation by the US Food and Drug Administration (FDA), works by interfering with the PD-L1 protein on tumour cells. By doing this, it may help T cells in the blood, ...

    Comment?

  10. Want to avoid sugar but bored of water? Try these drink optionsRead the original story w/Photo

    4 hrs ago | Stuff.co.nz

    ... Sugars, and Schools, stated, "Several non-nutritive sweeteners have been accepted by the US Food and Drug Administration as safe and have shown good safety over time." Despite what you might read and hear, the overwhelming research shows diet drinks ...

    Comment?

  11. Health Care Update - May 2015 #4Read the original story w/Photo

    4 hrs ago | JD Supra

    ... up the Manager's amendment, Chairman Upton highlighted that the amendment would provide the Food and Drug Administration (FDA) with the funding it needs to implement the legislation, including creating an annual Cures Innovation Fund and exempting ...

    Comment?

  12. House OKs bill for experimental drugs for terminal patientsRead the original story w/Photo

    4 hrs ago | WHNT-TV Huntsville

    The bill would authorize access to drugs that have completed a clinical trial but that haven't been approved for general use by the U.S. Food and Drug Administration.

    Comment?

  13. Boehringer Ingelheim gets FDA approval for 2 drugsRead the original story w/Photo

    5 hrs ago | News Times

    German drugmaker Boehringer Ingelheim announced regulatory approval of two medications including an inhalation spray used to treat a variety of lung diseases such as bronchitis and emphysema. According to a statement released by the company earlier this week, the U.S. Food and Drug Administration has approved Stiolto Respimat, a once-daily treatment for patients suffering from chronic obstructive pulmonary disease, or COPD, a serious but treatable lung ailment.

    Comment?

  14. Canadian risk assessment finds GMO salmon susceptible to diseaseRead the original story

    5 hrs ago | Indybay.org

    A never-before-seen draft environmental review of AquaBounty Technologies' genetically engineered salmon reveals that Canadian government scientists disagree with the U.S. Food and Drug Administration on key questions related to the safety and performance of what may be the first GE animal approved for human consumption. In light of these findings, Food & Water Watch, Center for Food Safety, Friends of the Earth and Consumers Union today called on the FDA to terminate its ongoing review of GE salmon.

    Comment?

  15. Gov. Sandoval Signs 'Right to Try' Experimental Drug BillRead the original story w/Photo

    5 hrs ago | KTVN Reno

    ... less than a year to live to use drugs that have cleared the first phase of testing by the U.S. Food and Drug Administration. It exempts doctors from punishment if they prescribe experimental drugs under the provisions of the bill. Democratic ...

    Comment?

  16. Pizza Hut and Taco Bell Clean Up Their MenusRead the original story w/Photo

    6 hrs ago | Food Processing

    ConAgra Grocery Products unit agrees to plead guilty to a charge that it shipped contaminated peanut butter linked to a 2006-2007 nationwide outbreak of salmonella poisoning ConAgra Grocery Products LLC, Omaha, Neb., a subsidiary of ConAgra Foods Inc., has agreed to plead guilty and pay $11.2 million in fines and forfeitures connected with the charge that it shipped contaminated peanut butter linked to a 2006-2007 nationwide outbreak of salmonella poisoning, the Department of Justice announced May 20. Manufacturing products at a facility in Sylvester, Ga., ConAgra Grocery Products signed a statement admitting that it introduced Peter Pan and private-label peanut butter contaminated with salmonella into interstate commerce during the 2006 through 2007 outbreak.

    Comment?

  17. Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking...Read the original story w/Photo

    6 hrs ago | AndhraNews

    Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa Capsules BEDMINSTER, NJ and DUBLIN, IRELAND-- - Amarin Corporation plc , announced today that Judge Randolph D. Moss of the federal district court for the District of Columbia has granted Amarin's motion for summary judgment in the company's lawsuit against the United States Food and Drug Administration seeking an order requiring FDA to recognize five-year, New Chemical Entity , marketing exclusivity for Vascepa Amarin believes based on the court's ruling that Vascepa is entitled to five-year marketing exclusivity starting from FDA's approval of Vascepa in July 2012, thus extending NCE exclusivity through July 25, 2017.

    Comment?

  18. Report: FBI investigating medical device that spread cancer in womenRead the original story w/Photo

    8 hrs ago | WTSP-TV Saint Petersburg

    ... it had the effect of spreading cancerous tissue throughout the abdomen and pelvis. The U.S. Food and Drug Administration issued a warning about the cancer risk in April 2014, saying morcellation could "significantly worsen...the patient's likelihood ...

    Comment?

  19. FDA approves new drugs for irritable bowel syndromeRead the original story w/Photo

    9 hrs ago | PhysOrg Weblog

    Two new drugs for adults with irritable bowel syndrome with diarrhea were approved by the U.S. Food and Drug Administration on Wednesday. "For some people, IBS can be quite disabling, and no one medication works for all patients suffering from this gastrointestinal disorder," Dr. Julie Beitz, director of the Office of Drug Evaluation III in FDA's Center for Drug Evaluation and Research, said in an agency news release.

    Comment?

  20. Long-Term Care Legislation in Florida - Regulatory Compliance Impacts ...Read the original story w/Photo

    15 hrs ago | jdsupra.com

    ... drugs, biological products, or devices. According to the bill's staff analysis, the Food and Drug Administration (FDA) has a process to allow patients to gain access to unapproved investigational drugs, but the process may be burdensome. This bill ...

    Comment?